Novel σ receptor ligands attenuate the locomotor stimulatory effects of cocaine

European Journal of Pharmacology

Volumn 365, Issue 1, 1999, Pages 35-38

  McCracken, Kari A ^a   Bowen, Wayne D ^b   Matsumoto, Rae R ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Cocaine; Locomotor activity; Psychomotor effect

Indexed keywords

BD 1063; COCAINE; N [2 (3,4 DICHLOROPHENYL)ETHYL] N METHYL 2 (1 PYRROLIDINYL)ETHYLAMINE; SIGMA OPIATE RECEPTOR; SIGMA RECEPTOR LIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; GUINEA PIG; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RAT; RECEPTOR AFFINITY; WITHDRAWAL SYNDROME;

ANIMALS; BINDING, COMPETITIVE; COCAINE; DOPAMINE UPTAKE INHIBITORS; ETHYLAMINES; GUINEA PIGS; MALE; MICE; MOTOR ACTIVITY; PIPERAZINES; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, DOPAMINE D2; RECEPTORS, OPIOID; RECEPTORS, PHENCYCLIDINE; RECEPTORS, SEROTONIN; RECEPTORS, SIGMA;

EID: 0033555570     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00876-0     Document Type: Article

References (13)

1. 3H ]-(+)-pentazocine: a potent and highly selective benzomorphan-based probe for sigma-1 receptors Mol. Neuropharmacol. 3:1993;117-126.
2. 3H ]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors FEBS Lett. 251:1989;53-58.
3. De Costa B.R., Radesca L., Di Paolo L., Bowen W.D. Synthesis, characterization, and biologic evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines: structural requirements and binding affinity at the σ receptor. J. Med. Chem. 35:1992;38-47.
4. De Costa B.R., He X.-H., Linders J.T.M., Dominguez C., Gu Z.-Q., Williams W., Bowen W.D. Synthesis and evaluation of conformationally restricted N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamines at σ receptors: II. Piperazines, bicyclic amines, bridged bicyclic amines and miscellaneous compounds. J. Med. Chem. 36:1993;2311-2320.
5. Harris G.C., Hedaya M.A., Pan W.J., Kalivas P. β-adrenergic antagonism alters the behavioral and neurochemical responses to cocaine. Neuropsychopharmacology. 14:1996;195-204.
6. Hellewell S.B., Bruce A., Feinstein G., Orringer J., Williams W., Bowen W.D. Rat liver and kidney contain high densities of sigma-1 and sigma-2 receptors: characterization by ligand binding and photo affinity labeling. Eur. J. Pharmacol. 268:1994;9-18.
7. Kuhar M.J., Ritz M.C., Sharkley J. Cocaine receptors on dopamine transporters mediate cocaine-reinforced behavior. NIDA Research Monograph. 8:1988;14-22.
8. Matsumoto R.R., Bowen W.D., Walker J.M. Down-regulation of sigma receptors by chronic haloperidol. Prog. Clin. Biol. Res. 328:1990;125-128.
9. Matsumoto R.R., Bowen W.D., Tom M.A., Vo V.N., Truong D.D., de Costa B.R. Characterization of two novel σ receptor ligands: anti-dystonic effects in rats suggest σ receptor antagonism. Eur. J. Pharmacol. 280:1995;301-310.
10. Matsumoto R.R., Friedman M., Blyden J.F., Brown M., de Costa B.R. Novel sigma ligands attenuate cocaine-induced toxicity and locomotor stimulation. Soc. Neurosci. Abstr. 23:1997;937.6.
11. Menkel M., Terry P., Pontecorvo M., Katz J.L., Witkin J.M. Selective σ ligands block stimulant effects of cocaine. Eur. J. Pharmacol. 201:1991;251-252.
12. Walker, J.M., Martin, W.J., Hohman, A.G., Hemstreet, M.K., Roth, J.S., Leitner, M.L., Weiser, S.D., Patrick, S.L., Patrick, R.L., Matsumoto, R.R., 1994. Role of sigma receptors in brain mechanisms of movement. In: Itzhak, Y. (Ed.), Sigma Receptors. Academic Press, San Diego, CA, pp. 205-224.
13. Witkin J.M., Terry P., Menkel M., Hickey P., Pontecorvo M., Ferkany J., Katz J.L. Effects of the selective sigma receptor ligand, 6-[6-(4-hydroxypiperidinyl)hexyloxy]-3-methylflavone (NPC 16377), on behavioral toxic effects of cocaine. J. Pharmacol. Exp. Ther. 266:1993;473-482.